Ethical issues in nanomedicine

IFMBE Proceedings

Volumn 36, Issue , 2011, Pages 9-12

  Graur, Florin ^a   Elisei, R ^a   Szasz, A ^a   Neagos, H C ^a,b   Muresan, A ^a   Furcea, L ^a,b   Neagoe, I ^b   Braicu, C ^b   Katona, G ^c   Diudea, M ^c  

^a Surgical Clinic II   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

Ethics; Nanomedicine; Nanotechnology

Indexed keywords

HEALTH CARE; MEDICAL NANOTECHNOLOGY; NANOTECHNOLOGY;

ETHICAL ASPECTS; ETHICAL ISSUES; ETHICS; HUMAN BODIES;

PHILOSOPHICAL ASPECTS;

EID: 84962135956     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-642-22586-4_3     Document Type: Conference Paper

References (27)

1. Resnik D, Tinkle S. (2007) Ethics in Nanomedicine. Nanomedicine (Lond). June; 2(3): 345–350.
2. Bawa R and Johnson S. (2008). Emerging issues in nanomedicine and ethics. In: Allhoff F and Lin P (editors.), Nanoethics: Emerging Debates, Springer, Dordrecht (in press)
3. Reisch MS: (2007) Nano goes big time. Chemical & Engineering News 85(4), 22-25.
4. Reflections on ethical aspects of nanomedicine. http://www.capurro.de/nanoethics.html
5. Hunt W. (2004) Nanomaterials: nomenclature, novelty and necessity. Journal of Materials. Vol 56 no. 10: 13-18.
6. Report. (2007) Nanotechnology in Healthcare. The freedonia Group, Inc. Cleveland, Ohio
7. Chen, L.C. and Boufford, J.I. (2005) Fatal flows-doctors on the move. N Engl J Med 353, 1850-1852
8. Saini A (2007) Making the poor pay. New Scientist 193(2597), 20
9. Capurro R: Reflections on Ethical Aspects of Nanomedicine http://www.capurro.de/nanoethics.html
10. Cameron NM de S (2006).The NELSI Imperative: nano ethics, legal and social issues and federal policy development. Nanotechnology Law & Business 3(2), 159-166
11. Naam (2005), More Than Human. Broadway Books, New York. p.5 www.morethanhuman.org.
12. Daniels Norm (1992) Growth Hormone Therapy for Short Stature: Can We Support the Treatment/Enhancement Distinction? Growth: Genetics & Hormones 8.S1: 46-8.
13. Juengst Eric (1997) Can Enhancement Be Distinguished from Prevention in Genetic Medicine?, Journal of Medicine and Philosophy 22 125-42.
14. Freitas Robert A. Jr. (1998) Exploratory Design in Medical Nanotechnology: A Mechanical Artificial Red Cell Artificial Cells, Blood Substitutes, and Immobil. Biotech. 26411-430.
15. Lin P, Allhoff F (2006) Nanoethics and Human Enhancement:A Critical Evaluation of Recent Arguments. Nanotechnology Perceptions 2 (2006) 47–52
16. Bruce D: Ethical Issues in Nano-Medicine and Enhancement: an Overview. www.edinethics.co.uk/nano/nanoeth9a-med.doc
17. Oberdorster G, Oberdorster E, Oberdorster J (2005). Nanotoxicity: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Persp. 113, 823-839
18. Strom B (2006) How the U.S. drug safety system should be changed. JAMA 295, 2072-2075
19. Donaldson K. (2006) Resolving the nanoparticles paradox. Nanomedicine.1:229–34.
20. Ethics and Nanomedicine – Analysis Of The Issues and Principles To Be Faced By The Medical Application of Nanotechnology. http://www.azonano.com/Details.asp?ArticleID=1705
21. Resnik D, Tinkle S. (2006) Ethical issues in clinical trials involving nanomedicine. Contemp Clin Trials. Nov 17; Considers ethical issues in nanomedicine clinical trials.
22. Beyond Therapy (2003) Biotechnology and the Pursuit of Happiness. President’s Council on Bioethics http://www.bioethics.gov/reports/beyoundtherapy/
23. Kuiken T (2011) Nanomedicine and ethics: is there anything new or unique? Wiley Interdisciplinary Reviews: Nanomedicine and Nano-biotechnology. Volume 3, Issue 2, pages 111–118, March/April
24. Evers J, Aerts S, De Tavernier J. (2008) An ethical argument in favor of nano-enabled diagnostics in livestock disease control. Nanoethics, 2:163–178.
25. Spagnolo AG, Daloiso V. (2008) Outlining ethical issues in nanotech-nologies. Bioethics, 23:394–402.
26. Ferrari M, Philibert MA, Sanhai WR. (2009) Nanomedicine and society. Clin Pharmacol Ther, 85:466–467.
27. The Institute of Medicine: The Future of Drug Safety: Promoting and Protecting the Health of the Public. www.nap.edu/catalog.php?record_id=11750#toc